Exelixis Inc. (EXEL)

Market is closed

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

News

1 - 10
Next >>

15 Best Stocks to Buy According to Jim Simons' Renaissance Technologies

Even after his passing in 2024, billionaire investor and mathematician Jim Simons remains known as the "Quant King" of hedge funds due to the extraordinary success of Renaissance Technologies, his quantitative...

Keep Reading →

May 11th, 2025 - Hedge Funds News

20 Large-Cap Stocks Insiders and Short Sellers Are Dumping Like Crazy

Uncertainty is around every corner of the U.S. stock market, affecting investors’ decisions.

Keep Reading →

May 2nd, 2025 - Hedge Funds Insider Trading Market Movers News

7 Most Profitable Biotech Stocks To Buy Right Now

With improved market conditions, innovative breakthroughs, and more investor interest, the biotechnology industry is gaining new traction.

Keep Reading →

March 30th, 2025 - Hedge Funds News

15 Best Biotech Stocks to Buy According to Billionaires

Although biotech stocks had a "challenging" year in 2024, JPMorgan believes that some of the industry's companies could see significant growth in the months to come.

Keep Reading →

March 15th, 2025 - Hedge Funds News

10 Best Immunology Stocks To Buy Now

Immunology is a rapidly advancing field with significant potential for growth, especially in the realm of biotech and pharmaceutical companies.

Keep Reading →

February 28th, 2025 - Hedge Funds News

Renaissance Technologies Portfolio: Top 10 Stock Picks

The American quant hedge fund Renaissance Technologies is known for using statistical and mathematical tools to drive its investment programs.

Keep Reading →

February 22nd, 2025 - Hedge Funds News

Exelixis, Inc. (NASDAQ:EXEL) Q4 2024 Earnings Call Transcript

Operator: Good day, ladies and gentlemen, and welcome to the Exelixis Fourth Quarter and Fiscal Year 2024 Financial Results Conference Call. My name is Sherry, and I'll be your operator for today.

Keep Reading →

February 13th, 2025 - News Transcripts

What Makes Exelixis (EXEL) an Investment Bet?

Riverwater Partners, an investment management company, released its “Sustainable Value Strategy” Q4 2024 investor letter. A copy of the letter can be downloaded here.

Keep Reading →

January 21st, 2025 - Hedge Fund Investor Letters News

10 Best Performing Biotech Stocks in 2024

The biotechnology sector is expanding quickly due to rising demand for novel therapies, advancement in technology, and government assistance.

Keep Reading →

December 23rd, 2024 - Hedge Funds News

Exelixis, Inc. (NASDAQ:EXEL) Q3 2024 Earnings Call Transcript

Operator: Good day, ladies and gentlemen, and welcome to Exelixis Third Quarter 2024 Financial Results Conference Call. My name is Towanda, and I will be your operator for today.

Keep Reading →

October 31st, 2024 - News Transcripts